C-Level Executives, Presidents, VPs and Directors
An error occurred trying to play the stream. Please reload the page and try again. Close
“Upheaval is the name of the game in healthcare these days with transformational vertical combinations like that of CVS Health and Aetna, Cigna and Express Scripts, and the Rite Aid-Albertsons deal, all representing a land grab ahead of Amazon’s nascent plans to disrupt the prescription pharmacy market.
This supply chain disruption is putting downward pressure on prices even as revolutionary gene therapies catapult into a market with jaw-dropping price tags, fueling heated political debate and leaving investors, companies and policy makers scrambling to get ahead of the trends.
The meteoric changes are impacting every component of the turbulent $2.8 trillion dollar healthcare market, prompting mega-hospital deals and ever-larger consolidations of doctor specialty groups, heated auctions for biotech assets and a wave of data analytic innovation that has rapidly transformed everything from drug development to healthcare delivery.
With uncertainty comes opportunity, however. Join us in September as we explore the changes and opportunities they present with our industry-leading speakers and panels.”